The Canadian Cancer Clinical Trials Network
The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada. 3CTN will provide support and coordination for a network of teams at cancer treatment centres and hospitals. With regional participation, 3CTN will enable sites to increase their capacity and capability to conduct academic trials.
3CTN Stakeholder Meeting
The Canadian Cancer Clinical Trials Network held its stakeholder meeting on November 6, 2015 in Toronto. View the slide deck for more information.
3CTN Guide to Patient and Public Involvement (PPI)
In collaboration with the 3CTN Lay Representative Advisory Committee, 3CTN is pleased to release a new document that will serve the cornerstone of the PPI Program – download the 3CTN Guide to PPI below.
To view present and past 3CTN Performance Reports, please click here.
The table below provides an overview on reporting obligations and timelines for 3CTN award recipients.
April 20, 2016
3CTN has released its April Newsletter. View this issue for more information on 3CTN Progress to date.